Pfizer Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PFE.DE | AZN | SNY | MRK | BMY | BIIB | |
|---|---|---|---|---|---|---|
| Market cap | 152.04B | 269.03B | 100.82B | 364.57B | 129.49B | 37.15B |
| P/E (TTM) | 40.4 | 25.9 | 22.1 | 117.3 | 14.0 | 44.7 |
| Forward P/E | — | 15.3 | 8.0 | 16.0 | 9.6 | 15.3 |
| Price/book | 2.0 | 5.3 | 1.3 | 8.7 | 5.8 | 2.0 |
| Dividend yield | 5.72% | 1.90% | 5.90% | 2.27% | 4.12% | — |
| 1-year change | +25.02% | +0.99% | −17.27% | +71.92% | +39.45% | +60.57% |
| Today | +0.53% | +2.98% | +2.70% | −1.41% | +3.71% | +4.33% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All PFE.DE news ›Pfizer announces layoffs at NC facilities, leaving workers and local leaders seeking answers
RALEIGH, N.C. (WTVD) -- Pfizer has announced a new round of layoffs affecting its facilities in Rocky Mount and Sanford, raising concerns about the potential impact on workers, families and local economies across eastern and central North…
Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Advances 2%
Moderna shares are surging ahead of a closely watched cancer data presentation in Madrid, but the company's razor-thin revenue base means a single readout could swing the stock sharply in either direction. Moderna‘s (NASDAQ:MRNA | MRNA…
Former FDA chief on Pfizer's board gets successor censored for praising natural immunity: report
Scott Gottlieb's Pfizer relationship was reportedly not disclosed to Twitter in considering how to treat Brett Giroir's tweet. A former FDA commissioner who now sits on Pfizer's board successfully throttled a tweet by his interim…
'The truth lost': Appeals court clears Pfizer leaders in COVID vaccine critic's censorship lawsuit
Five months after the Trump administration settled with former New York Times drug industry reporter Alex Berenson for its predecessor's role in getting Twitter to deplatform the COVID-19 vaccine critic in 2021, the pharmaceutical leaders…
We lost. I lost. The truth lost. Pfizer won.
I owe you this update, though it stings very much to write. Last Thursday’s hearing in Berenson v Gottlieb was difficult for me to watch. I was sure we had lost when I left the courtroom, on the 17th floor of the Thurgood Marshall United…
The Promise on Hold: Takeda and Pfizer still to respond to help a Nigerian child with Hodgkin Lymphoma
Please comment and share this post. A child in Nigeria battling relapsed Hodgkin lymphoma urgently needs brentuximab vedotin, a potentially life saving medication that has data supporting its use in relapses. A few weeks ago I contacted…
Pfizer's Stock Is Finally Showing Signs of Life. Could This Be the Start of a Much Bigger Rally?
Pfizer (PFE -0.47%) is a stock that the market has largely forgotten about for multiple years, languishing and struggling to rise in value despite having strong fundamentals and an attractive valuation. Recently, however, it's been picking…
Ex-White House, Pfizer Execs Squelch Vaccine Skeptic’s Appeal
Bloomberg Law News Independent journalist Alex Berenson failed in his Second Circuit effort to revive his class action claiming the Biden administration and drug company allies pressured Twitter to remove him from the platform after he…
Pfizer (PFE) Gets a Hold from Wells Fargo
In a report released on October 16, Derek Archila from Wells Fargo maintained a Hold rating on Pfizer, with a price target of $28.00. The company’s shares closed last Friday at $29.58. According to TipRanks, Archila is a 5-star analyst…
Pfizer’s Dividend Freeze Raises a Bigger Question About Its Cash Flow
Pfizer's 5.8% yield looks tempting until you check what the dividend is actually costing the company relative to its cash generation. The math behind that payout is more uncomfortable than the headline numbers suggest. Total debt rose from…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
theglobeandmail.com21
-
marketscreener.com17
-
247wallst.com16
-
fool.com13
-
seekingalpha.com10
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.